Search Results for "clobetasol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for clobetasol. Results 1 to 7 of 7 total matches.
See also: Cormax

Clobetasol Propionate (Clobex) Spray for Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Mar 27, 2006  (Issue 1231)
Clobetasol Propionate (Clobex) Spray for Psoriasis ...
The FDA has approved a new spray formulation of the super-high-potency corticosteroid clobetasol propionate 0.05% (Clobex - Galderma) for treatment of moderate to severe plaque psoriasis in adults. Clobetasol propionate is also available as a cream, ointment, gel, solution, foam, lotion and shampoo.
Med Lett Drugs Ther. 2006 Mar 27;48(1231):27-8 |  Show IntroductionHide Introduction

Topical Corticosteroids

   
The Medical Letter on Drugs and Therapeutics • Nov 15, 1991  (Issue 857)
Halobetasol ointment bid was as effective as clobetasol (Temovate) ointment bid for 18 to 25 days’ treatment ...
Two new topical corticosteroids - fluticasone (Cutivate - Glaxo), a mediumpotency product, and halobetasol propionate (Ultravate - Westwood-Squibb), a superhigh- potency drug- were recently approved for marketing by the US Food and Drug Administration.
Med Lett Drugs Ther. 1991 Nov 15;33(857):108-10 |  Show IntroductionHide Introduction

Ruxolitinib Cream (Opzelura) for Nonsegmental Vitiligo

   
The Medical Letter on Drugs and Therapeutics • Oct 03, 2022  (Issue 1660)
, such as mometasone or clobetasol, or a topical calcineurin inhibitor, such as tacrolimus or pimecrolimus ...
The 1.5% cream formulation of the Janus kinase (JAK) inhibitor ruxolitinib (Opzelura – Incyte) has been approved by the FDA for topical treatment of nonsegmental vitiligo (NSV) in patients ≥12 years old. Opzelura is the first product to be approved by the FDA for this indication. It was previously approved for treatment of atopic dermatitis.
Med Lett Drugs Ther. 2022 Oct 3;64(1660):158-9 |  Show IntroductionHide Introduction

Comparison Table: Some Topical Corticosteroids (online only)

   
The Medical Letter on Drugs and Therapeutics • May 08, 2017  (Issue 1520)
$112.60 (15 g x 2) Diprolene (Merck) 180.90 (15 g x 2) Clobetasol propionate – generic 0.05% cream Apply ...
View the Comparison Table: Some Topical Corticosteroids
Med Lett Drugs Ther. 2017 May 8;59(1520):e91-5 |  Show IntroductionHide Introduction

Drugs for Atopic Dermatitis

   
The Medical Letter on Drugs and Therapeutics • Jun 15, 2020  (Issue 1600)
Diprolene (Merck) 202.50/50 g Clobetasol propionate 0.05% generic oint, cream, gel 34.70/30 g lotion ...
Atopic dermatitis (AD; also known as eczema) is frequently associated with other atopic disorders such as allergic rhinitis, asthma, and food allergy. It commonly presents in infancy and early childhood and has a relapsing course, often improving by adolescence, but sometimes persisting into (or first appearing in) adulthood or even old age.
Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96 |  Show IntroductionHide Introduction

Drugs for Plaque Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 2024  (Issue 1712)
. Superpotent topical corticosteroids, such as clobetasol propionate 0.05%, can cause adrenal suppression when ...
Mild to moderate plaque psoriasis can be treated with topical drugs and phototherapy. Patients with moderate to severe disease generally require systemic therapy. Guidelines for the treatment of psoriasis with topical therapy, phototherapy, and systemic drugs have recently been published.
Med Lett Drugs Ther. 2024 Sep 30;66(1712):153-60   doi:10.58347/tml.2024.1712a |  Show IntroductionHide Introduction

Drugs of Choice for Cancer

   
Treatment Guidelines from The Medical Letter • Mar 01, 2003  (Issue 7)
steroids: clobetasol, diflorasone, photochemotherapy) halobetasol, betamethasone; Systemic chemotherapy ...
The tables in this article list drugs used for treatment of cancer in the USA and Canada and their major adverse effects. The choice of drugs in Table I is based on the opinions of Medical Letter consultants. Some drugs are listed for indications for which they have not been approved by the US Food and Drug Administration. In some cases, such as elderly patients or those with many co-morbid illnesses, the regimen of choice might not be suitable. For many of the cancers listed, surgery and/or radiation therapy may be the treatment of choice or may also be part of the management. Anticancer...
Treat Guidel Med Lett. 2003 Mar;1(7):41-52 |  Show IntroductionHide Introduction